Table 1. Largest series A financing rounds for companies founded in 2012. Four of the largest series A rounds for biotechs founded in 2012 went to companies based in the San Francisco Bay Area. Among the 23 companies founded in 2012 that disclosed venture financing that year, there were 16 U.S. companies, 3 based in the U.K. and 1 each based in Australia, Belgium, Russia and Switzerland. The largest series A round in 2012 was $49 million and raised by Histogenics Corp., a Massachusetts-based regenerative medicine company that develops products for cartilage repair. The company was founded in 2000 and thus was excluded from this table.

Source: BCIQ: BioCentury Online Intelligence

Company

Business area

Location

Amount raised ($M)

Global Blood Therapeutics Inc.

Hematology

South San Francisco, Calif.

40.7

MyoKardia Inc.

Cardiovascular disease

San Francisco, Calif.

38.0

Allakos Inc.

Inflammation

San Francisco, Calif.

32.0

Labrys Biologics Inc.

Neurology

San Francisco, Calif.

31.0

Aclaris Therapeutics Inc.

Dermatology

Malvern, Pa.

21.0

BioMotiv LLC

Cancer; cardiovascular disease; neurology

Cleveland, Ohio

21.0